SLT as primary glaucoma treatment may offer reduced cost, better efficacy than eye drops

Selective laser trabeculoplasty may be more effective and cheaper than eye drops when used as primary glaucoma management, Nathan Radcliffe, MD, said at the virtual OSN New York meeting.
β€œIn most cases, the laser is going to be more cost-effective than either the generic or the brand-name drops,” Radcliffe said.
Eye drops are associated with low adherence, improper application, unwanted side effects and wasted dosing.
The LiGHT trial, which investigated laser therapy vs. medications in patients with newly diagnosed ocular hypertension and glaucoma, randomly assigned 718 patients into

Full Story β†’